Noramco™
Josh Hoerner is currently the General Manager of Purisys, LLC and Vice President, R&D Noramco LLC. Prior to this role, Josh held various positions at Noramco™, Merck, General Electric Global Research, and Pfizer Pharmaceuticals, with a focus on analytical research and development in the pharmaceutical industry. Josh earned their Ph.D. in Analytical Chemistry from the University of Massachusetts Amherst and a Bachelor of Science in Chemistry from Hobart and William Smith Colleges.
This person is not in any offices
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III